Vista will combine the business with portfolio company Vitera Healthcare Solutions according to details released to the New York Stock Exchange.
The $20.35-a-share deal represented a premium of about 19 per cent to the stock’s $17.13 closing price on Monday.
Vista’s newly combined business, which will run under the Greenway brand, will serve about 13,000 medical organisations and 100,000 providers.
The firm closed its flagship fund on $3.5bn in 2012, beating its initial target by $1bn.
Earlier today it emerged that Vista was reportedly set to close its second small and mid-cap investment fund on slightly less than $1bn.
Vista is also raising a maiden credit fund of about $600m and a co-investment fund that is targeting $1bn according to Dow Jones, which cited a person familiar with the fundraising.
Copyright © 2013 AltAssets